MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Prepaid expenses andother current assets$22,343K Accounts receivable$3,492K Cash and cashequivalents$693,472K Restricted cash$1,449K Property and equipment,net$4,564K Operating leaseright-of-use assets$17,463K Total current assets$719,307K Total assets$742,783K Total liabilities andstockholders' equity$742,783K Total stockholders'equity$703,580K Total liabilities$39,203K Accumulated deficit-$458,304K Additional paid-in capital$1,161,880K Operating leaseliabilities, net of current...$15,111K Total currentliabilities$24,092K Common stock, par valueof 0.0001 per share...$4K Accrued expenses andother current...$15,174K Current tax liability$4,147K Deferred revenue$155K Current portion ofoperating lease...$2,318K Accounts payable$2,298K
Balance Sheet
source: myfinsight.com

Keros Therapeutics, Inc. (KROS)

Keros Therapeutics, Inc. (KROS)